|
| HOME |
|
Archive News
2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002
To download and view any of the documents listed below, click on the links. To view or print the Portable Document Format (PDF) files, you will need Adobe Acrobat Viewer installed on your system.
If you do not have the latest Adobe Viewer, please download it here before you attempt to open the desired file.
| 2005 |
|
|
| December 22, 2005 |
2006 Notice of Annual General Meeting and Proxy Form |
|
| December 12, 2005 |
Peptech participates in Domantis capital raising |
|
| December 7, 2005 |
Domantis continues development momentum |
|
| December 6, 2005 |
Domantis alliance with global pharmaceutical company |
|
| November 21, 2005 |
Mel Bridges presented with Ausbiotech prestigious award |
|
| November 7, 2005 |
Peptech Full Year Results 2005 |
|
| November 7, 2005 |
Peptech full year results surpass expectations |
|
| November 7, 2005 |
Investor presentation on full year results 2005 |
|
| October 27, 2005 |
Peptech announces exciting results from Domantis trial |
|
| October 12, 2005 |
Peptech announces Suprelorin® twin pack competition winner |
|
| October 4, 2005 |
Peptech announces appointment of new CEO |
|
| September 15, 2005 |
Peptech Update - 2005 |
|
| September 13, 2005 |
Suprelorin12® submitted for registration in Australia |
|
| September 12, 2005 |
Manufacturing Agreement for anti-TNF dAb therapeutic |
|
| September 8, 2005 |
Suprelorin® submitted for registration in Europe |
|
| September 2, 2005 |
Domantis successful in patent opposition proceedings |
|
| August 24, 2005 |
Biosceptre Prostate Cancer Results |
|
| August 17, 2005 |
Peptech Reiterates Strong Growth Prospects |
|
| July 20, 2005 |
Peptech and Domantis formalise new cancer collaboration |
|
| July 7, 2005 |
Third protective US patent for male dog contraceptive |
|
| June 27, 2005 |
Peptech partner Biosceptre granted patent for cancer target |
|
| June 22, 2005 |
Biosceptre ovarian cancer diagnosis breakthrough |
|
| June 9, 2005 |
Peptech Half-year Report to shareholders |
|
| June 8, 2005 |
Peptech advances anti-TNF dAb |
|
| June 2, 2005 |
Domantis delivers dual targeting drug candidate to Abbott> |
|
| May 25, 2005 |
Peptech presentation at Citigroup Medtech Biotech Bullring |
|
| May 6, 2005 |
Peptech announces profit upgrade on strong half-year results |
|
| April 21, 2005 |
Share buy-back update |
|
| April 19, 2005 |
Peptech announces second arthritis drug success |
|
| April 12, 2005 |
Peptech Update April 2005 |
|
| April 6, 2005 |
Peptech advances TNF drug |
|
| April 5, 2005 |
Peptech Remains Perfectly Positioned For Growth |
|
| March 29, 2005 |
Peptech Appoints UBS as Broker for Share Buy-Back |
|
| March 23, 2005 |
Peptech announcement on Domantis Deal |
|
| March 15, 2005 |
Peptech announces share buy-back |
|
| February 23, 2005 |
Peptech fulfils commitment to Domantis |
|
| February 17, 2005 |
Peptech expands market potential for dog contraception |
|
| February 10, 2005 |
Peptech appoints new director to drive global profile |
|
| February 7, 2005 |
AGM - General |
|
| February 7, 2005 |
AGM - Cancer Update |
|
| February 7, 2005 |
AGM presentations |
|
| January 25, 2005 |
Peptech declares a franked dividend |
|
| January 25, 2005 |
Peptech investee Domantis joins heart disease project |
|
| January 20, 2005 |
Peptech approved to market Ovuplant® in UK |
|
| January 12, 2005 |
Peptech interest Domantis appoints new Chairman |
|
|
|
